Minimizing human infection from Escherichia coli O157:H7 using GUMBOS.

scientific article published on 26 February 2013

Minimizing human infection from Escherichia coli O157:H7 using GUMBOS. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JAC/DKT010
P8608Fatcat IDrelease_pol7pklb25b43jfzogjhpv2tzu
P932PMC publication ID3654221
P698PubMed publication ID23447139
P5875ResearchGate publication ID235750569

P50authorRavirajsinh N JadejaQ43051817
Bilal El-ZahabQ54364649
P2093author name stringMin Li
Isiah M Warner
Daniel Hayes
Jeffery A Hobden
Marsha R Cole
Marlene E Janes
P2860cites workAntiseptics and disinfectants: activity, action, and resistanceQ24550729
Nephrotoxic and hepatotoxic effects of triclosan and chlorhexidine in ratsQ28319763
Near-infrared fluorescent nanoGUMBOS for biomedical imagingQ33638220
Prevalence, antibiotic susceptibility, and diversity of Escherichia coli O157:H7 isolates from a longitudinal study of beef cattle feedlotsQ33989285
Chemical sensing in mammalian host-bacterial commensal associationsQ34006799
The mechanism of action of chlorhexidineQ34239704
Drug synergism: its detection and applicationsQ34337018
Options for the control of enterohaemorrhagic Escherichia coli in ruminantsQ35025039
Cationic antiseptics: diversity of action under a common epithetQ36257280
Antimicrobial resistance of Escherichia coli and therapeutic implicationsQ36292004
Association of 1-1 salts in waterQ36463403
Interaction index and different methods for determining drug interaction in combination therapyQ36811252
Diet, Escherichia coli O157:H7, and cattle: a review after 10 years.Q37436825
Verocytotoxin-producing Escherichia coli (VTEC).Q37467549
Impact of the direct application of therapeutic agents to the terminal recta of experimentally colonized calves on Escherichia coli O157:H7 shedding.Q41939923
Location of chlorhexidine in DMPC model membranes: a neutron diffraction studyQ43111995
In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acidQ43166557
Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic materialQ44041868
Inflammatory response to different endodontic irrigating solutions.Q44227251
Effects of the antibiotic ionophores monensin, lasalocid, laidlomycin propionate and bambermycin on Salmonella and E. coli O157:H7 in vitroQ44282625
Effect of feeding the ionophores monensin and laidlomycin propionate and the antimicrobial bambermycin to sheep experimentally infected with E. coli O157:H7 and Salmonella typhimuriumQ44366106
Interaction of the bisbiguanides chlorhexidine and alexidine with phospholipid vesicles: evidence for separate modes of actionQ45152220
Basic microbiological techniques used in antibacterial drug discovery.Q51296128
Design and analysis of drug combination experiments.Q51968000
Some toxicological observations on chlorhexidine.Q53852769
Design, synthesis, and biological evaluation of β-lactam antibiotic-based imidazolium- and pyridinium-type ionic liquids.Q54364540
Antimicrobial susceptibility of Escherichia coli O157 and other enterohaemorrhagic Escherichia coli isolated in Italy.Q54590976
The membrane destabilising action of the antibacterial agent chlorhexidineQ72080168
The use of chlorhexidineQ78415214
Structure and magnetic behavior of transition metal based ionic liquidsQ80478728
Systemic toxicity following ingestion of the chlorhexidine gluconate solution: a case reportQ83173047
Enhanced membrane transport of pharmaceutically active protic ionic liquidsQ84972776
Solubility properties of chlorhexidine saltsQ94706597
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectEscherichia coliQ25419
P304page(s)1312-1318
P577publication date2013-02-26
P1433published inJournal of Antimicrobial ChemotherapyQ6294770
P1476titleMinimizing human infection from Escherichia coli O157:H7 using GUMBOS
P478volume68

Reverse relations

cites work (P2860)
Q90153478Hyaluronic Acid-Cellulose Composites as Patches for Minimizing Bacterial Infections
Q38888005Recycling antibiotics into GUMBOS: a new combination strategy to combat multi-drug-resistant bacteria.

Search more.